Reader sentiment, not investment advice. One vote per visitor; click again to change it.
ANI Pharmaceuticals (ANIP) is trading at $72.58, up 0.55% on the day. Its market value of $1.67B makes it the 2909th largest of the 3132 companies we follow.
It is close to the bottom of its 52-week range ($69.58 to $97.00), 25.2% under the high.
The stock changes hands at 15.8 times trailing earnings.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Composite of 2 factors below, ranked against the 3132 U.S. stocks BeStock covers.
Cheaper on P/E than most of BeStock’s coverage scores higher.
Trading closer to its 52-week high than most peers scores higher.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
ANIP is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2021-01-04, the strategy has returned 389% (231.1% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.
Quote as of Oct 5, 2026 10:20 pm ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 3,132 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
$72.58 is the latest print for ANIP, a move of +0.55% against yesterday's close of $72.18. Today's low and high so far: $71.76 and $73.40.
Equity value comes to $1.67B at the current price. By that measure it is number 2909 of the 3132 names in our coverage.
Buyers pay 15.8 times the last twelve months of profit (EPS $3.32).
The year's floor is $69.58 and the ceiling $97.00. Shares are 25.2% away from that ceiling.
Our data shows no dividend paid by ANI Pharmaceuticals over the trailing twelve months.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on ANIP.